Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-22 3:24 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | 9,029,624 7.700% | 9,029,624 (New Position) | View | |
| 2024-03-06 12:40 pm Purchase | 13D | Arcutis Biotherapeutics Inc. ARQT | Frazier Life Sciences VIII L.P. | 8,862,478 7.800% | 21,052 (+0.24%) | View |
| 2024-03-06 10:31 am Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | JENNISON ASSOCIATES LLC | 12,128,533 10.800% | 3,062,451 (+33.78%) | View |
| 2024-02-14 3:58 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | PRUDENTIAL FINANCIAL INC PRU | 9,884,137 10.470% | 233,326 (+2.42%) | View |
| 2024-02-13 4:58 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | VANGUARD GROUP INC | 4,896,513 5.190% | 4,896,513 (New Position) | View |
| 2024-02-13 12:29 pm Sale | 13G | Arcutis Biotherapeutics Inc. ARQT | SUVRETTA CAPITAL MANAGEMENT LLC | 9,534,837 9.990% | -57,375 (-0.60%) | View |
| 2024-02-13 09:26 am Sale | 13G | Arcutis Biotherapeutics Inc. ARQT | Polar Capital Holdings Plc | 6,297,688 6.670% | -820,256 (-11.52%) | View |
| 2024-02-12 09:52 am Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | MORGAN STANLEY MS | 6,093,497 6.500% | 6,093,497 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | Rubric Capital Management LP | 6,644,530 7.040% | 6,644,530 (New Position) | View |
| 2024-02-08 12:52 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | JENNISON ASSOCIATES LLC | 9,066,082 9.600% | 9,066,082 (New Position) | View |
| 2024-01-31 4:54 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | Point72 Asset Management L.P. | 4,867,706 5.200% | 3,680,108 (+309.88%) | View |
| 2024-01-29 3:26 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | BlackRock Inc. BLK | 5,916,546 6.300% | 2,036,144 (+52.47%) | View |
| 2024-01-23 10:26 am Sale | 13G | Arcutis Biotherapeutics Inc. ARQT | STATE STREET CORP STT | 1,525,045 1.620% | -2,154,340 (-58.55%) | View |
| 2023-11-16 1:13 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | Polar Capital Holdings Plc | 7,117,944 7.560% | 7,117,944 (New Position) | View |
| 2023-11-13 09:02 am Sale | 13G | Arcutis Biotherapeutics Inc. ARQT | FMR LLC | 3,551,261 3.771% | -5,587,912 (-61.14%) | View |
| 2023-11-09 2:54 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | PRUDENTIAL FINANCIAL INC PRU | 9,650,811 10.250% | 9,650,811 (New Position) | View |
| 2023-11-07 3:33 pm Sale | 13G | Arcutis Biotherapeutics Inc. ARQT | BlackRock Inc. BLK | 3,880,402 4.100% | -1,333,856 (-25.58%) | View |
| 2023-10-30 5:03 pm Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | SUVRETTA CAPITAL MANAGEMENT LLC | 9,592,212 9.990% | 9,592,212 (New Position) | View |
| 2023-10-26 4:11 pm Purchase | 13D | Arcutis Biotherapeutics Inc. ARQT | Frazier Life Sciences VIII L.P. | 8,841,426 9.400% | 96,108 (+1.10%) | View |
| 2023-02-14 4:04 pm Sale | 13G | Arcutis Biotherapeutics Inc. ARQT | Point72 Asset Management L.P. | 1,187,598 1.900% | -1,470,364 (-55.32%) | View |